William Davis, MD
Cardiovascular Disease · Auburn, ALNPI 1790716165
Payments from drug & device makers
Across 127 payments — averaging $13,254 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- American Regent$1.5M
- Amgen$60K
- Regeneron$36K
- Boehringer Ingelheim Pharma GmbH & Co.kg$36K
- Boehringer Ingelheim International GmbH$16K
- Pfizer$11K
- plus $18K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| American Regent | 18 | $1,505,713 |
| Amgen | 13 | $60,162 |
| Regeneron | 19 | $35,959 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 3 | $35,784 |
| Boehringer Ingelheim International GmbH | 6 | $15,999 |
| Pfizer | 4 | $11,422 |
| Akcea Therapeutics, Inc. | 2 | $7,327 |
| Sanofi US Services Inc. | 1 | $5,000 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $4,500 |
| Novartis | 12 | $180 |
| Lexicon Pharmaceuticals, Inc. | 7 | $145 |
| Idorsia Pharmaceuticals US Inc | 1 | $122 |
| Actelion Pharmaceuticals US, Inc. | 6 | $122 |
| Zimmer Biomet | 1 | $113 |
| Esperion Therapeutics, Inc. | 5 | $112 |
| Novo Nordisk | 2 | $99 |
| Heartflow, Inc. | 2 | $51 |
| Bayer | 2 | $46 |
| United Therapeutics Corporation | 3 | $44 |
| Boehringer Ingelheim | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $34 |
| Merck | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Impulse Dynamics (USA) Inc. | 1 | $25 |
| Lundbeck LLC | 1 | $20 |
| Medicomp Inc | 1 | $20 |
| Amryt Pharma Holdings Ltd | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Medtronic | 1 | $16 |
| Elutia, Inc. | 2 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
How this compares
$1,683,223 in reported general payments places this provider in the 95th percentile of 292 cardiovascular disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Auburn
- Mustafa AhmedBirmingham$2.5M
- Brian FoleyAlexander City$2.5M
- Andreas MuenchDothan$2M
- Alain BouchardBirmingham$1.9M
- Walter HaughtHuntsville$1.6M
- Christopher BrownMobile$1.4M
- Shi-Chi ChengHuntsville$1.2M
- Mahomed SalameAnniston$1.2M
- Steven JonesBirmingham$1M
- Dennis ThomasMobile$894K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.